Invesco
NXTC icon

Invesco’s NextCure NXTC Stock Holding History

Invesco’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,313
Closed -$95K – 4081
2021
Q4 		$95K Sell
1,313
-140
-10% -$11.7K ﹤0.01% 3910
2021
Q3 		$117K Buy
1,453
+19
+1% +$1.67K ﹤0.01% 3909
2021
Q2 		$138K Sell
1,434
-229
-14% -$23.4K ﹤0.01% 3849
2021
Q1 		$200K Buy
+1,663
New +$241K ﹤0.01% 3679
2020
Q1 		– Sell
-823
Closed -$556K – 3695
2019
Q4 		$556K Sell
823
-1,849
-69% -$928K ﹤0.01% 3205
2019
Q3 		$989K Buy
+2,672
New +$869K ﹤0.01% 3003

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Invesco's NXTC Position: Q1 2022 in Review

Invesco sold out of NextCure (NXTC) in Q1 2022, closing a stake of 1,313 shares — an estimated $95K sold.

Invesco first reported a position in NXTC in Q3 2019 and held it in 6 quarters. The position peaked at $989K in Q3 2019. 59 funds tracked by Wall St. Rank hold NXTC as of Q1 2022.

  • Invesco reported no remaining NextCure position as of Q1 2022 after selling out during the quarter.
  • Invesco sold 1,313 NextCure shares in Q1 2022, an estimated $95K.
  • Invesco first reported a position in NextCure in Q3 2019 and held it in 6 quarters.
  • Invesco's NextCure position peaked at $989K in Q3 2019.
  • 59 funds tracked by Wall St. Rank held NextCure as of Q1 2022.

Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.